Press Releases

November 17, 2023

Friends Statement on W. Kimryn Rathmell’s Nomination by President Biden as Director of the National Cancer Institute

Friends of Cancer Research (Friends) applauds President Biden for nominating Dr. W. Kimryn Rathmell as Director of the National Cancer Institute (NCI) and extends our deepest gratitude to recently confirmed Director of the National Institutes of Health, Dr. Monica Bertagnolli, for her steadfast leadership as Director of the NCI. “Dr. Rathmell brings extensive scientific expertise…

Read More

August 15, 2023

27th Cancer Leadership Awards Recipients Announced

FDA Commissioner Califf to Receive the Ellen V. Sigal Advocacy Leadership Award Congresswoman Dingell to Receive the Marlene A. Malek Public Service Award Washington, DC – August 15, 2023 – Friends of Cancer Research (Friends) is proud to announce our 2023 Cancer Leadership Awards honorees: Commissioner of the U.S. Food and Drug Administration, Dr. Robert Califf,…

Read More

May 26, 2023

New Data Release: Friends of Cancer Research at the 2023 ASCO Annual Meeting

Friends of Cancer Research (Friends) is excited to present data from three current projects at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. These findings are catalyzing meaningful improvements in oncology drug development and informing regulatory policy and patient care. Abstract Details  Changes in ctDNA levels as an early indicator of outcomes in…

Read More

May 15, 2023

Friends Statement on Monica Bertagnolli’s Nomination as Director of the National Institute of Health

Friends of Cancer Research (Friends) thanks President Joe Biden for nominating Dr. Monica Bertagnolli as the Director of the National Institute of Health (NIH). “At this critical time for innovation at the NIH, Dr. Bertagnolli will be the visionary leader we need,” said Ellen Sigal, Chair & Founder of Friends of Cancer Research.  As the…

Read More

April 3, 2023

Friends of Cancer Research Commends the National Cancer Institute’s National Cancer Plan

Friends of Cancer Research (Friends) commends the National Cancer Institute (NCI) and their Director Dr. Monica Bertagnolli, for the recently announced National Cancer Plan. This critical and innovative plan provides a framework for collaboration and partnership across agencies seeking to improve the lives of millions of cancer patients and families.  “Dr. Bertagnolli and the Biden…

Read More

March 30, 2023

Friends of Cancer Research Applauds Rep. DeGette and Rep. Bucshon for Introducing The VALID Act

Friends of Cancer Research (Friends) applauds Larry Bucshon (R-IN) and Diana DeGette (D-CO) for their leadership introducing the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act).  The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play a critical role in patient care.…

Read More

March 16, 2023

Friends of Cancer Research Announces Election of City of Hope’s Dr. Edward S. Kim to Board of Directors

Friends of Cancer Research (Friends) is excited to announce the addition of City of Hope physician executive Edward S. Kim, M.D., M.B.A., FACP, FASCO, to its Board of Directors. Dr. Kim, recognized as one of the top cancer experts in the nation, is Physician-in-Chief and Senior Vice President, City of Hope Orange County, Construction Industries Alliance…

Read More

February 23, 2023

New Friends of Cancer Research Manuscript Furthers Work in Aligning Disparate Real-World Data in Oncology

A new manuscript by Friends of Cancer Research (Friends) published today in JCO Clinical Cancer Informatics, details a framework to align electronic patient reported outcome (ePRO) data capture across ePRO tools to assess the value of ePROs for improving patient outcomes. This work can help expedite efforts to generate robust real-world data (RWD). PROs are…

Read More

December 8, 2022

Statement by Friends of Cancer Research on the VALID Act of 2022

Friends of Cancer Research (Friends) is pleased to support the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) and urges Congress to include this as part of the 2023 omnibus appropriations bill. The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play…

Read More

November 7, 2022

Friends’ HRD Harmonization Project Announces In Silico Data Readout

Friends of Cancer Research (Friends) is excited to announce new data from the Homologous Recombination Deficiency (HRD) Harmonization Project shared this weekend at The Association of Molecular Pathology Annual Meeting. The HRD Harmonization Project is a unique research partnership focused on understanding the variability in HRD assays and developing strategies to align methodology for measuring…

Read More